Impact of Relugolix vs. Leuprolide on Quality of Life in Advanced Prostate Cancer | Dr. Peush Bajpai скачать в хорошем качестве

Impact of Relugolix vs. Leuprolide on Quality of Life in Advanced Prostate Cancer | Dr. Peush Bajpai

Watch Dr. Peush Bajpai from Delhi present on the Impact of Relugolix Versus Leuprolide on Quality of Life in men with advanced prostate cancer, based on the results from the Phase 3 HERO Study. This presentation is part of Day 1 of the 05th Knowledge Series for Genitourinary Cancers - Best of 2023, held on May 11, 2024, at The Pride Aero City, Delhi. The event is organized by the Cancer Research And Statistic Foundation, with support from the Institute of Pulmonology Medical Research & Development and Sunrise Oncology Centre. Dr. Bajpai explores how Relugolix compares to Leuprolide in terms of quality of life outcomes for patients undergoing treatment for advanced prostate cancer. Read more about the HERO Study here: European Urology - HERO Study. Stay informed on the latest research and its impact on patient care in prostate cancer. #ProstateCancer #Relugolix #Leuprolide #QualityOfLife #CancerResearch #GenitourinaryCancers #Bestof2023 #Oncology #HEROStudy #EuropeanUrology #CancerConference #CRSF2024 #AdvancedProstateCancer #MedicalResearch #CancerCare